Immunic Presents New Phase 2 Data Supporting Vidofludimus Calcium in Progressive MS
NEW YORK, May 28, 2026 Immunic, Inc. has unveiled new analyses from its Phase 2 CALLIPER trial evaluating vidofludimus...
Monoclonal Antibody
Advertisement
Johnson & Johnson Wins FDA Label Expansion for TREMFYA
HORSHAM, Pennsylvania, May 28, 2026 Johnson & Johnson has secured a major regulatory milestone after the U.S. Food and...
Vanda Gains Japan Orphan Status for Imsidolimab
WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Jade Biosciences Doses First Patient With JADE201
SAN FRANCISCO and VANCOUVER, British Columbia, May 26, 2026 Jade Biosciences announced the first participant has been dosed in...
Apogee to Reveal Phase 2 Zumilokibart AD Data
SAN FRANCISCO and BOSTON, May 26, 2026 Apogee Therapeutics announced it will report Part B 16-week clinical data from...
Advertisements
Marea MAR002 Acromegaly Data Set for ENDO 2026
SOUTH SAN FRANCISCO, Calif., May 26, 2026 Marea Therapeutics announced that new data from its first-in-human Phase 1 clinical...
Roche’s Gazyva Moves Closer to Public Access in Canada for Lupus Nephritis
MISSISSAUGA, Ontario, May 22, 2026 Roche Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive reimbursement recommendation...
Elanco Launches Befrena for Canine Allergy and Itch Relief
Indianapolis, Indiana, USA – May 18, 2026 Elanco Animal Health Incorporated announced the phased U.S. launch of Befrena™ (tirnovetmab),...
Infex Therapeutics Reports Positive Phase IIa RESP-X Data in Bronchiectasis
Alderley Park, Cheshire, U.K., May 21, 2026 Infex Therapeutics announced positive Phase IIa clinical trial results for RESP-X (INFEX702)...
Samsung Bioepis Launches First Japan Biosimilar
INCHEON, South Korea, May 20, 2026 Samsung Bioepis has announced the official launch of Ustekinumab BS 45 mg Syringe...
Advertisement
